The cell cryopreservation market size has grown exponentially in recent years. It will grow from $10.21 billion in 2023 to $12.65 billion in 2024 at a compound annual growth rate (CAGR) of 23.8%. The growth during the historic period is driven by several factors, including the rising demand for cell-based therapies, increased focus on biomedical research, growing necessity for organ transplantation, heightened R&D efforts in cell-based therapies, and the expanding utilization of cryopreserved cells.
The cell cryopreservation market size is expected to see exponential growth in the next few years. It will grow to $29.9 billion in 2028 at a compound annual growth rate (CAGR) of 24%. In the forecast period, growth is fueled by several factors, increased demand for in vitro fertilization (IVF) procedures, advancements in organ transplantation techniques, expanding biobanking activities, a rise in chronic disease cases, and supportive government initiatives and funding. Major trends during this period encompass advancements in cryopreservation techniques, MRNA vaccine storage and transportation improvements, enhancements in cryoprotectants and freezing methods, a growing inclination towards personalized medicine, and progress in stem cell research.
The growth of the cell cryopreservation market is anticipated to be driven by the increasing number of organ transplantation procedures. Organ transplantation involves replacing damaged or failing organs with healthy ones from donors, a procedure on the rise due to factors such as organ failure from various causes such as hereditary abnormalities, infections, traumas, and chronic diseases. In the context of organ transplantation, cell cryopreservation plays a vital role by freezing and storing cells from organs, preserving their viability for future use, improving graft success rates, and reducing immune rejection. For instance, data from the Health Resources and Services Administration in January 2024 showed a significant increase in organ transplants performed in 2023 compared to previous years, highlighting the upward trend in organ transplantation that fuels the demand for cell cryopreservation.
Companies in the cell cryopreservation market are focusing on developing advanced cryopreservation medium solutions to meet evolving customer needs. Cryopreservation medium solutions are specialized formulations that freeze cells or tissues at ultra-low temperatures, enabling long-term storage and transport while maintaining their viability and functionality. For example, Pluristyx Inc., a US-based provider of tools and technologies for cellular therapies, recently introduced PluriFreeze, a proprietary cryopreservation medium solution designed to accelerate the development of stem cell therapies. PluriFreeze is specifically tailored to support the growth of induced pluripotent stem cells (iPSCs), offering a novel approach to enhance the efficiency and quality of iPSC therapy development, particularly in stem cell therapy research and commercialization.
In December 2021, CooperSurgical Inc., a US-based medical equipment manufacturer, acquired Generate Life Sciences for $1.6 billion. This acquisition strengthened CooperSurgical's position in serving fertility clinics, obstetricians, and gynecologists by expanding its product and service offerings in cell cryopreservation. Generate Life Sciences, known for its expertise in cell cryopreservation services, brought valuable capabilities and a strong clinical reputation to CooperSurgical's portfolio.
Major companies operating in the cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Corning Inc., STEMCELL Technologies, Cryoport Inc., BioLife Solutions Inc, Nkarta Inc., Tn-Sanso Corporation, Coya Therapeutics, FUJIFILM Irvine Scientific, Artiva Biotherapeutics, Acorn Biolabs Inc., ThermoGenesis Holdings Inc., Evia Bio Inc., Wideblue Limited, Akron Biotech, Captivate Bio LLC, Pluristyx Inc., CryoCrate LLC, PanTHERA CryoSolutions, ParaTechs Corporation, Plus Therapeutics, X-Therma Inc., Protein Technologies Limited.
North America was the largest region in the cell cryopreservation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell cryopreservation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cell cryopreservation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Cell cryopreservation involves cooling cells to sub-zero temperatures, typically in liquid nitrogen at -196°C, to preserve them. This process stops all biological activity and metabolism, enabling cells to be stored for extended periods without deterioration. Cryoprotective agents are essential to prevent ice crystal formation, which could harm cell structures during freezing and thawing.
The primary products of cell cryopreservation include cell freezing media, equipment, and consumables. Equipment comprises specialized tools such as controlled-rate freezing apparatuses or isopropanol chambers designed to freeze cells at specific rates. This technology finds applications in preserving various cell types such as hepatocytes, stem cells, oocytes, embryotic cells, sperm cells, among others. These products reach end-users through channels such as biopharmaceutical and pharmaceutical companies, research institutes, Biobanks, in vitro fertilization (IVF) clinics, and similar entities.
The cell cryopreservation market research report is one of a series of new reports that provides cell cryopreservation market statistics, including the cell cryopreservation industry global market size, regional shares, competitors with cell cryopreservation market share, detailed cell cryopreservation market segments, market trends, and opportunities, and any further data you may need to thrive in the cell cryopreservation industry. These cell cryopreservation market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cell cryopreservation market consists of sales of cryoprotectants, freezing containers, and cryogenic storage systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The cell cryopreservation market size is expected to see exponential growth in the next few years. It will grow to $29.9 billion in 2028 at a compound annual growth rate (CAGR) of 24%. In the forecast period, growth is fueled by several factors, increased demand for in vitro fertilization (IVF) procedures, advancements in organ transplantation techniques, expanding biobanking activities, a rise in chronic disease cases, and supportive government initiatives and funding. Major trends during this period encompass advancements in cryopreservation techniques, MRNA vaccine storage and transportation improvements, enhancements in cryoprotectants and freezing methods, a growing inclination towards personalized medicine, and progress in stem cell research.
The growth of the cell cryopreservation market is anticipated to be driven by the increasing number of organ transplantation procedures. Organ transplantation involves replacing damaged or failing organs with healthy ones from donors, a procedure on the rise due to factors such as organ failure from various causes such as hereditary abnormalities, infections, traumas, and chronic diseases. In the context of organ transplantation, cell cryopreservation plays a vital role by freezing and storing cells from organs, preserving their viability for future use, improving graft success rates, and reducing immune rejection. For instance, data from the Health Resources and Services Administration in January 2024 showed a significant increase in organ transplants performed in 2023 compared to previous years, highlighting the upward trend in organ transplantation that fuels the demand for cell cryopreservation.
Companies in the cell cryopreservation market are focusing on developing advanced cryopreservation medium solutions to meet evolving customer needs. Cryopreservation medium solutions are specialized formulations that freeze cells or tissues at ultra-low temperatures, enabling long-term storage and transport while maintaining their viability and functionality. For example, Pluristyx Inc., a US-based provider of tools and technologies for cellular therapies, recently introduced PluriFreeze, a proprietary cryopreservation medium solution designed to accelerate the development of stem cell therapies. PluriFreeze is specifically tailored to support the growth of induced pluripotent stem cells (iPSCs), offering a novel approach to enhance the efficiency and quality of iPSC therapy development, particularly in stem cell therapy research and commercialization.
In December 2021, CooperSurgical Inc., a US-based medical equipment manufacturer, acquired Generate Life Sciences for $1.6 billion. This acquisition strengthened CooperSurgical's position in serving fertility clinics, obstetricians, and gynecologists by expanding its product and service offerings in cell cryopreservation. Generate Life Sciences, known for its expertise in cell cryopreservation services, brought valuable capabilities and a strong clinical reputation to CooperSurgical's portfolio.
Major companies operating in the cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Corning Inc., STEMCELL Technologies, Cryoport Inc., BioLife Solutions Inc, Nkarta Inc., Tn-Sanso Corporation, Coya Therapeutics, FUJIFILM Irvine Scientific, Artiva Biotherapeutics, Acorn Biolabs Inc., ThermoGenesis Holdings Inc., Evia Bio Inc., Wideblue Limited, Akron Biotech, Captivate Bio LLC, Pluristyx Inc., CryoCrate LLC, PanTHERA CryoSolutions, ParaTechs Corporation, Plus Therapeutics, X-Therma Inc., Protein Technologies Limited.
North America was the largest region in the cell cryopreservation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell cryopreservation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cell cryopreservation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Cell cryopreservation involves cooling cells to sub-zero temperatures, typically in liquid nitrogen at -196°C, to preserve them. This process stops all biological activity and metabolism, enabling cells to be stored for extended periods without deterioration. Cryoprotective agents are essential to prevent ice crystal formation, which could harm cell structures during freezing and thawing.
The primary products of cell cryopreservation include cell freezing media, equipment, and consumables. Equipment comprises specialized tools such as controlled-rate freezing apparatuses or isopropanol chambers designed to freeze cells at specific rates. This technology finds applications in preserving various cell types such as hepatocytes, stem cells, oocytes, embryotic cells, sperm cells, among others. These products reach end-users through channels such as biopharmaceutical and pharmaceutical companies, research institutes, Biobanks, in vitro fertilization (IVF) clinics, and similar entities.
The cell cryopreservation market research report is one of a series of new reports that provides cell cryopreservation market statistics, including the cell cryopreservation industry global market size, regional shares, competitors with cell cryopreservation market share, detailed cell cryopreservation market segments, market trends, and opportunities, and any further data you may need to thrive in the cell cryopreservation industry. These cell cryopreservation market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cell cryopreservation market consists of sales of cryoprotectants, freezing containers, and cryogenic storage systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Cell Cryopreservation Market Characteristics3. Cell Cryopreservation Market Trends and Strategies32. Global Cell Cryopreservation Market Competitive Benchmarking33. Global Cell Cryopreservation Market Competitive Dashboard34. Key Mergers and Acquisitions in the Cell Cryopreservation Market
4. Cell Cryopreservation Market - Macro Economic Scenario
5. Global Cell Cryopreservation Market Size and Growth
6. Cell Cryopreservation Market Segmentation
7. Cell Cryopreservation Market Regional and Country Analysis
8. Asia-Pacific Cell Cryopreservation Market
9. China Cell Cryopreservation Market
10. India Cell Cryopreservation Market
11. Japan Cell Cryopreservation Market
12. Australia Cell Cryopreservation Market
13. Indonesia Cell Cryopreservation Market
14. South Korea Cell Cryopreservation Market
15. Western Europe Cell Cryopreservation Market
16. UK Cell Cryopreservation Market
17. Germany Cell Cryopreservation Market
18. France Cell Cryopreservation Market
19. Italy Cell Cryopreservation Market
20. Spain Cell Cryopreservation Market
21. Eastern Europe Cell Cryopreservation Market
22. Russia Cell Cryopreservation Market
23. North America Cell Cryopreservation Market
24. USA Cell Cryopreservation Market
25. Canada Cell Cryopreservation Market
26. South America Cell Cryopreservation Market
27. Brazil Cell Cryopreservation Market
28. Middle East Cell Cryopreservation Market
29. Africa Cell Cryopreservation Market
30. Cell Cryopreservation Market Competitive Landscape and Company Profiles
31. Cell Cryopreservation Market Other Major and Innovative Companies
35. Cell Cryopreservation Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Cell Cryopreservation Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on cell cryopreservation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cell cryopreservation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell cryopreservation market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Cell Freezing Media; Equipment; Consumables2) By Application: Hepatocytes; Stem Cells; Oocytes And Embryotic cells; Sperm Cells; Other Applications
3) By End-Use Channel: Biopharmaceutical And Pharmaceutical Companies; Research Institutes; Biobanks; In Vitro Fertilization (IVF) Clinics; Other End-Use Channels
Key Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Corning Inc.; STEMCELL Technologies
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Merck KGaA
- Corning Inc.
- STEMCELL Technologies
- Cryoport Inc.
- BioLife Solutions Inc
- Nkarta Inc.
- Tn-Sanso Corporation
- Coya Therapeutics
- FUJIFILM Irvine Scientific
- Artiva Biotherapeutics
- Acorn Biolabs Inc.
- ThermoGenesis Holdings Inc.
- Evia Bio Inc.
- Wideblue Limited
- Akron Biotech
- Captivate Bio LLC
- Pluristyx Inc.
- CryoCrate LLC
- PanTHERA CryoSolutions
- ParaTechs Corporation
- Plus Therapeutics
- X-Therma Inc.
- Protein Technologies Limited
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 175 |
Published | July 2024 |
Forecast Period | 2024 - 2028 |
Estimated Market Value ( USD | $ 12.65 Billion |
Forecasted Market Value ( USD | $ 29.9 Billion |
Compound Annual Growth Rate | 24.0% |
Regions Covered | Global |